Neovasc Inc. Change in inventories

Change in inventories of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Change in inventories growth rates and interactive chart.


Highlights and Quick Summary

  • Change in inventories for the quarter ending March 31, 2022 was $77.2 Thousand (a -36.0% decrease compared to previous quarter)
  • Year-over-year quarterly Change in inventories decreased by -115.88%
  • Annual Change in inventories for 2021 was $-632 Thousand (a 171.13% increase from previous year)
  • Annual Change in inventories for 2020 was $-233 Thousand (a -36.52% decrease from previous year)
  • Annual Change in inventories for 2019 was $-367 Thousand (a -375.74% decrease from previous year)
  • Twelve month Change in inventories ending March 31, 2022 was $-503 Thousand (a -21.93% decrease compared to previous quarter)
  • Twelve month trailing Change in inventories decreased by -11.3% year-over-year
Trailing Change in inventories for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$-503 Thousand $-644 Thousand $-897 Thousand $-567 Thousand
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Change in inventories of Neovasc Inc.

Most recent Change in inventoriesof NVCN including historical data for past 10 years.

Interactive Chart of Change in inventories of Neovasc Inc.

Neovasc Inc. Change in inventories for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.08
2021 $0.12 $-0.21 $-0.49 $-0.06 $-0.63
2020 $-0.13 $0.12 $-0.02 $-0.19 $-0.23
2019 $-0.14 $-0.0 $-0.01 $-0.21 $-0.37
2018 $-0.07 $-0.02 $0.07 $0.16 $0.13
2017 $0.07 $-0.03 $0.05 $-0.26 $-0.18
2016 $0.41 $0.51 $-0.44 $-0.48 $-0.0
2015 $-0.27 $0.02 $-0.04 $-0.27
2014 $0.0 $0.0

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.